Denmark· DK-28106783322
Naproxen "Mashal"
A naproxen product containing naproxen, registered in Denmark by Mashal Healthcare A/S. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Naproxen is registered in 15 of 19 countries.
Countries holding a registration under ATC M01AE02 (naproxen), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Naproxen · ATC M01AE02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of naproxen costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.16 in Italy to $0.82 in Switzerland — a ×4.9 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Naproxen · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.82
- IT Italy$0.16
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- NAPROXEN
- Manufacturer
- Mashal Healthcare A/S
- Country
- Denmark (DK)
- ATC code
- M01AE02
- ATC class
- Naproxen
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106783322
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
495 interactions on record for naproxen.
Graded by severity as the source publishes them — 58 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naproxen · interactions on record
495 records
- 58 severe
- 176 moderate
- 17 minor
- 161 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
83 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M01AE02
Naproxen, as other registers publish it.
- United States24/7 Life by 7-Eleven Naproxen SodiumLil' Drug Store Products, Inc.
- United StatesAleveBayer HealthCare LLC.
- FinlandAleveBayer Oy
- PolandAleveInPharm Sp. z o.o.
- United StatesAleveLil' Drug Store Products, Inc
- United StatesAleveNavajo Manufacturing Company Inc.
- PolandAleveDelfarma Sp. z o.o.
- PolandAleveBayer Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5e23501-f5fe-48bc-a384-ac8f340539ca GET /v1/drugs/e5e23501-f5fe-48bc-a384-ac8f340539ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tabletter",
"source": "dkma",
"strength": "500 mg",
"auth_role": "DKMA",
"dk_drugid": "28106783322",
"substance": "NAPROXEN",
"auth_procedure": "Par-Imp",
"in_medicinpriser": false,
"registration_date_serial": "44771"
}See everything about naproxen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.